AxoGen
AXGN
55.75
-0.60
-1.06%
AxoGen
US · AXGN
#2714 by market cap
Listed 1970
55.75
-0.60
-1.06%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
A Quick Look at Today's Ratings for AxoGen(AXGN.US), With a Forecast Between $48 to $55Market Newswire · 2026/4/30
-
Rating change
Jefferies Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $50Market Newswire · 2026/7/6
-
Rating change
CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $50Market Newswire · 2026/5/4
-
Rating change
Raymond James Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $53Market Newswire · 2026/9/25
-
Rating change
Leerink Partners Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $52Market Newswire · 2026/10/13
-
Rating change
Truist Financial Initiates AxoGen(AXGN.US) With Buy Rating, Announces Target Price $60Market Newswire · 2026/8/26
-
Barclays Maintains AxoGen(AXGN.US) With Buy Rating, Cuts Target Price to $50Market Newswire · 2026/10/23
-
Truist Financial Maintains AxoGen(AXGN.US) With Buy Rating, Announces Target Price $53Market Newswire · 2026/10/1
-
Rating change
A Quick Look at Today's Ratings for AxoGen(AXGN.US), With a Forecast Between $53 to $55Market Newswire · 2026/7/31
-
Rating change
CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $55Market Newswire · 2026/10/5
-
Rating change
Barclays Initiates AxoGen(AXGN.US) With Buy Rating, Announces Target Price $55Market Newswire · 2026/10/8
-
Rating change
Truist Financial Maintains AxoGen(AXGN.US) With Buy RatingMarket Newswire · 2026/9/29
-
Rating change
Wells Fargo Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $48Market Newswire · 2026/10/3
-
CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $60Market Newswire · 2026/11/12
-
Rating change
Jefferies Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $55Market Newswire · 2026/9/29
-
Rating change
BofA Securities Initiates AxoGen(AXGN.US) With Buy Rating, Announces Target Price $52Market Newswire · 2026/10/12
-
Rating change
Lake Street Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $55Market Newswire · 2026/10/5
-
A Quick Look at Today's Ratings for AxoGen(AXGN.US), With a Forecast Between $56 to $65Market Newswire · 2026/10/30
-
Lake Street Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $60Market Newswire · 2026/11/10
-
Rating change
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), AxoGen (AXGN) and Biohaven Ltd. (BHVN)TipRanks · 2026/9/30
-
Rating change
A Quick Look at Today's Ratings for AxoGen(AXGN.US), With a Forecast Between $50 to $50Market Newswire · 2026/4/29
-
Earnings Flash (AXGN) Axogen, Inc. Posts Q3 Adjusted EPS $0.21 per Share, Vs. FactSet Est of $0.13MT Newswires · 2026/10/28
-
Rating change
CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $45Market Newswire · 2026/4/24
-
Rating change
Lake Street Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $50Market Newswire · 2026/4/23
-
Rating change
Lake Street Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $50Market Newswire · 2026/4/27
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
AxoGen discussion 0 comments